These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 972268)

  • 1. Intravenous injection of gentamicin and tobramycin without impairment of hearing.
    Dobbs SM; Mawer GE
    J Infect Dis; 1976 Aug; 134 Suppl():S114-7. PubMed ID: 972268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-blind comparison of the nephrotoxicity and auditory toxicity of gentamicin and tobramycin.
    Smith CR; Lipsky JJ; Laskin OL; Hellmann DB; Mellits ED; Longstreth J; Lietman PS
    N Engl J Med; 1980 May; 302(20):1106-9. PubMed ID: 6988713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled comparison of gentamicin and tobramycin nephrotoxicity.
    Matzke GR; Lucarotti RL; Shapiro HS
    Am J Nephrol; 1983; 3(1):11-7. PubMed ID: 6340504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical nephrotoxicity of tobramycin and gentamicin. A prospective study.
    Kumin GD
    JAMA; 1980 Oct; 244(16):1808-10. PubMed ID: 7420681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal toxicity. Tobramycin and gentamicin.
    Fry TL; Fried FA; Goven BA
    Invest Urol; 1977 Sep; 15(2):100-3. PubMed ID: 903207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and ototoxicity of gentamicin, tobramycin, and amikacin.
    Federspil P; Schätzle W; Tiesler E
    J Infect Dis; 1976 Aug; 134 Suppl():S200-5. PubMed ID: 972282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical evaluation of aminoglycoside toxicity: tobramycin versus gentamicin, a preliminary report.
    Fee WE; Vierra V; Lathrop GR
    J Antimicrob Chemother; 1978 May; 4 Suppl A():31-6. PubMed ID: 659347
    [No Abstract]   [Full Text] [Related]  

  • 8. Renal and auditory toxicity of high-dose, prolonged therapy with gentamicin and tobramycin in pseudomonas endocarditis.
    Tablan OC; Reyes MP; Rintelmann WF; Lerner AM
    J Infect Dis; 1984 Feb; 149(2):257-63. PubMed ID: 6421944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacologic studies or aminoglycoside antibiotics (amikacin, gentamicin, sisomicin, tobramycin)].
    Lode H; Grunert K; Kemmerich B; Koeppe P
    Adv Clin Pharmacol; 1978; 15():35-44. PubMed ID: 676877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Once-daily dosed gentamicin is more nephrotoxic than once-daily dosed tobramycin in clinically infected patients.
    van Maarseveen E; van Buul-Gast MC; Abdoellakhan R; Gelinck L; Neef C; Touw D
    J Antimicrob Chemother; 2014 Sep; 69(9):2581-3. PubMed ID: 24872345
    [No Abstract]   [Full Text] [Related]  

  • 11. Administration of tobramycin and gentamicin by the intravenous route every 6 hr in patients with normal renal function.
    Setia U; Gross PA
    J Infect Dis; 1976 Aug; 134 Suppl():S125-9. PubMed ID: 972270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gentamicin and tobramycin in patients with various infections--nephrotoxicity.
    Kahlmeter G; Hallberg T; Kamme C
    J Antimicrob Chemother; 1978 May; 4 Suppl A():47-52. PubMed ID: 659349
    [No Abstract]   [Full Text] [Related]  

  • 13. Occurrence and risk of cochleotoxicity in cystic fibrosis patients receiving repeated high-dose aminoglycoside therapy.
    Mulheran M; Degg C; Burr S; Morgan DW; Stableforth DE
    Antimicrob Agents Chemother; 2001 Sep; 45(9):2502-9. PubMed ID: 11502521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenously delivered aminoglycoside antibiotics, tobramycin and amikacin, are not ototoxic in mice.
    Ogier JM; Lockhart PJ; Burt RA
    Hear Res; 2020 Feb; 386():107870. PubMed ID: 31864009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nephrotoxicity of gentamicin and tobramycin given once daily or continuously in dogs.
    Reiner NE; Bloxham DD; Thompson WL
    J Antimicrob Chemother; 1978 May; 4 Suppl A():85-101. PubMed ID: 659354
    [No Abstract]   [Full Text] [Related]  

  • 16. Gentamicin and tobramycin penetration into synovial fluid.
    Dee TH; Kozin F
    Antimicrob Agents Chemother; 1977 Oct; 12(4):548-9. PubMed ID: 921252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid intravenous injection of tobramycin: suggested dosage schedule and concentrations in serum.
    Gillett AP; Falk RH; Andrews J; Wise R; Melikian V
    J Infect Dis; 1976 Aug; 134 Suppl():S110-3. PubMed ID: 985661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience with a once-daily dosing program of aminoglycosides in critically ill patients.
    Buijk SE; Mouton JW; Gyssens IC; Verbrugh HA; Bruining HA
    Intensive Care Med; 2002 Jul; 28(7):936-42. PubMed ID: 12122533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative toxicity of gentamicin versus tobramycin: a randomized prospective study.
    Fong IW; Fenton RS; Bird R
    J Antimicrob Chemother; 1981 Jan; 7(1):81-8. PubMed ID: 7204294
    [No Abstract]   [Full Text] [Related]  

  • 20. Prospective audit of an aminoglycoside consultative service in a general hospital.
    Li SC; Ioannides-Demos LL; Spicer WJ; Spelman DW; Tong N; McLean AJ
    Med J Aust; 1992 Sep; 157(5):308-11. PubMed ID: 1435470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.